文献速递临床试验与 GCP流行病学与生物统计

改善尼日利亚高血压控制方案的开发与评价(DEPIHCON):一项整群随机对照试验

Development and evaluation of a package to improve hypertension control in Nigeria [DEPIHCON]: a cluster-randomized controlled trial.
PubMed 文献 · Trials · 2022-05-02

该研究将在尼日利亚三个州采用混合方法设计,包括基线调查、整群随机对照试验和终线调查,评估经培训的社区导向资源人员(CORPs)参与高血压管理的效果。试验纳入200例高血压患者,干预组接受CORPs提供的社区筛查、转诊、诊断确认、初始治疗、每月家庭随访和健康教育及电话语音提醒,对照组接受常规照护,随访6个月,主要评价血压变化和心血管危险因素控制情况。

要点

  • 研究在尼日利亚三个州开展,采用混合方法设计,包括基线调查、整群随机对照试验和终线调查。
  • 干预组由经培训的社区导向资源人员(CORPs)提供社区血压筛查、转诊、诊断确认、初始治疗、每月家庭随访和健康教育。
  • 整群随机对照试验纳入200例高血压患者,随访6个月,评价血压降低和心血管危险因素预防效果。

核心结论

  • 该研究旨在评估利用经培训的社区导向资源人员(CORPs)改善尼日利亚高血压控制的效果。
  • 研究预期提高对高血压的认知、知识、观念、行为、态度和实践,从而减少尼日利亚的高血压。
  • 若证实有效,倡导政府接受并扩大CORPs在高血压照护中的应用是关键。

研究设计与样本

  • 在尼日利亚三个州开展干预研究,采用混合方法设计。
  • 基线调查采用半结构化预试验问卷,收集1704名≥18岁成年人的 demographics、临床数据、知识、高血压发生和危险因素信息。
  • 在每个州10个选定社区开展焦点小组讨论(FGD)和关键知情者访谈(KII),探索社区高血压经历、管理挑战和支持需求。
  • 整群随机对照试验纳入200例高血压患者,在每个州的干预组和对照组中随访6个月。
  • 终线调查在干预和对照社区进行,评价平均血压、控制率、知识和其他心血管危险因素比例的变化,并用FGD和KII评估参与者对CORPs提供干预的感知质量和可接受性。

临床怎么用

  • 干预包包括经培训的CORPs开展社区血压筛查和转诊、在卫生机构确认诊断和初始治疗,随后每月家庭随访照护,并提供高血压控制和健康生活方式健康教育,辅以电话语音提醒。
  • 对照组继续常规照护,即患者在自行选择的医院接受诊断、治疗和随访照护。
  • 作者认为若证实有效,倡导政府接受并扩大CORPs在高血压照护中的应用是关键。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nigeria's healthcare system capacity to stem the increasing trend in hypertension is limited in coverage, scope and manpower. Use of trained community-based care providers demonstrated to be an effective complement in improving access to, and supporting healthcare delivery has not been adequately examined for hypertension care in Nigeria. This study is proposed to evaluate the effectiveness of using trained community-oriented resource persons (CORPs) to improve hypertension control in Nigeria. METHODS: An intervention study will be conducted in three states using a mixed method design. First is a baseline survey using a semi-structured pre-tested questionnaire to collect information on demographics, clinical data, knowledge, occurrence and risk factors of hypertension among 1704 adults ≥18 years. Focus group discussions (FGD) and key informant interviews (KII) will be conducted to explore a community's experience of hypertension, challenges with hypertension management and support required to improve control in 10 selected communities in each state. The second is a cluster-randomized controlled trial to evaluate effect of a package on reduction of blood pressure (BP) and prevention of cardiovascular (CVD) risk factors among 200 hypertensive patients to be followed up in intervention and control arms over a 6-month period in each state. The package will include trained CORPs conducting community-based screening of BP and referral, diagnosis confirmation and initial treatment in the health facility, followed by monthly home-based follow-up care and provision of health education on hypertension control and healthy lifestyle enhanced by phone voice message reminders. In the control arm, the usual care (diagnosis, treatment and follow-up care in hospital of a patient's choice) will continue. Third, an endline survey will be conducted in both intervention and control communities to evaluate changes in mean BP, control, knowledge and proportion of other CVD risk factors. In addition, FGD and KII will be used to assess participants' perceived quality and acceptability of the interventions as delivered by CORPs. DISCUSSION: This research is expected to create awareness, improve knowledge, perception, behaviours, attitude and practices that will reduce hypertension in Nigeria. Advocacy for buy-in and scale up of using CORPs in hypertension care by the government is key if found to be effective. TRIAL REGISTRATION: PACTR Registry PACTR202107530985857 . Registered on 26 July 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ajayi IO, Oyewole OE, Ogah OS, et al. Development and evaluation of a package to improve hypertension control in Nigeria [DEPIHCON]: a cluster-randomized controlled trial. Trials. 2022. PMID: 35501887. doi:10.1186/s13063-022-06209-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。